SMTL ID : 7uyr.1

Crystal structure of TYK2 kinase domain in complex with compound 12

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x OVI: 2-(4-{[2-(2,6-difluorophenyl)-5-oxo-5H-pyrrolo[3,4-d]pyrimidin-4-yl]amino}phenyl)-N-ethylacetamide(Non-covalent)

OVI.1: 18 residues within 4Å: Chain A: R.13, D.14, L.15, G.16, E.17, V.23, A.40, E.91, Y.92, V.93, P.94, G.96, D.100, R.139, N.140, L.142, G.152, D.153 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.15, A:L.142, A:D.153 Hydrogen bonds: A:V.93, A:V.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Leit, S. et al., Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasis. Bioorg.Med.Chem.Lett. (2022)

Release Date

2022-08-24

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2

Related Entries With Identical Sequence